- Home
- HY vs IMNM Comparison
HY vs IMNM Comparison
Compare HY & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HY
- IMNM
- Stock Information
- Founded
- HY 1991
- IMNM 2006
- Country
- HY United States
- IMNM United States
- Employees
- HY N/A
- IMNM N/A
- Industry
- HY Construction/Ag Equipment/Trucks
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- HY Industrials
- IMNM Health Care
- Exchange
- HY Nasdaq
- IMNM Nasdaq
- Market Cap
- HY 735.1M
- IMNM 687.8M
- IPO Year
- HY N/A
- IMNM 2020
- Fundamental
- Price
- HY $39.56
- IMNM $8.40
- Analyst Decision
- HY Strong Buy
- IMNM Strong Buy
- Analyst Count
- HY 2
- IMNM 6
- Target Price
- HY $80.00
- IMNM $26.00
- AVG Volume (30 Days)
- HY 85.7K
- IMNM 1.4M
- Earning Date
- HY 05-06-2025
- IMNM 05-13-2025
- Dividend Yield
- HY 3.54%
- IMNM N/A
- EPS Growth
- HY 11.05
- IMNM N/A
- EPS
- HY 8.04
- IMNM N/A
- Revenue
- HY $4,308,200,000.00
- IMNM $9,041,000.00
- Revenue This Year
- HY N/A
- IMNM N/A
- Revenue Next Year
- HY $3.75
- IMNM $1,259.12
- P/E Ratio
- HY $4.91
- IMNM N/A
- Revenue Growth
- HY 4.61
- IMNM N/A
- 52 Week Low
- HY $34.13
- IMNM $5.15
- 52 Week High
- HY $84.44
- IMNM $19.07
- Technical
- Relative Strength Index (RSI)
- HY 46.09
- IMNM 59.16
- Support Level
- HY $37.54
- IMNM $6.96
- Resistance Level
- HY $40.00
- IMNM $8.88
- Average True Range (ATR)
- HY 1.84
- IMNM 0.66
- MACD
- HY 0.51
- IMNM 0.31
- Stochastic Oscillator
- HY 92.50
- IMNM 87.15
About HY Hyster-Yale Materials Handling Inc.
Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.